Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

301

HTML

3001

Figures (1-3)

175

Tables (1-3)

157

Sum=3634

May 26, 2011 (publication date) through Jul 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Stem Cells. May 26, 2011; 3(5): 43-52
Published online May 26, 2011. doi: 10.4252/wjsc.v3.i5.43

Table 2 Interfering test of cellular product

TAL (0.125EU/mL)	Bacterial endotoxin concentration (EU/mL)				Negative control	E (EU/mL)
TAL (0.125EU/mL)	0.25	0.125	0.063	0.032	Negative control	E (EU/mL)
A solution	+ +	+ +	- -	- -	- -	0.125
B solution	+ +	- -	- -	- -	- -	0.25
C solution	+ +	- -	- -	- -	- -	0.25

Citation: Guo CJ, Gao Y, Hou D, Shi DY, Tong XM, Shen D, Xi YM, Wang JF. Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood. World J Stem Cells 2011; 3(5): 43-52
URL: https://www.wjgnet.com/1948-0210/full/v3/i5/43.htm
DOI: https://dx.doi.org/10.4252/wjsc.v3.i5.43